Understanding Bleeding Disorder of Unknown Cause – EHC
EHC – European Haemophilia Consortium shared a post on LinkedIn:
”Extremely Rare Bleeding Disorder of the Month: Bleeding Disorder of Unknown Cause (BDUC)
For some people living with bleeding symptoms, even extensive testing cannot identify a clear cause. This condition is known as Bleeding Disorder of Unknown Cause (BDUC). Despite normal routine laboratory results, individuals may still experience frequent nosebleeds, easy bruising, heavy menstrual bleeding, or prolonged bleeding after injuries, dental work, or surgery.
Because BDUC has no single identified diagnostic marker, people can face long diagnostic journeys and uncertainty around treatment. Greater awareness and research are needed to better understand the condition and improve care for those affected.
Please note: in ‘Bleeding Disorder of Unknown Cause’, ‘Unknown’ means the underlying cause has not yet been identified. It does not mean the condition is unclear, imagined, or less serious!
Raising awareness helps ensure that people with unexplained bleeding symptoms are taken seriously, referred to specialists, and receive appropriate management and support.
Want to learn more?
Visit the ERIN Focus Area on our EHC Community website to explore webinars, podcasts, and publications dedicated to extremely rare bleeding disorders.”
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 16:02EU List of Critical Medicines Webinar Recording Now Available – EHC
-
Apr 14, 2026, 15:54Omar Adwan: Patterns of Anemia
-
Apr 14, 2026, 15:43Webinar on Aplastic Anemia Clinical Case – ASH
-
Apr 14, 2026, 15:42Heghine Khachatryan: Endometriosis Is Not Only a Pain Disorder
-
Apr 14, 2026, 15:36Alisha Tuck: Navigating the First Trimester with Ultrasound and Anticoagulation Management
-
Apr 14, 2026, 15:26Tijjani Balas: The End of ‘Type O Negative’ Shortages? – A New Era in Blood Transfusion
-
Apr 14, 2026, 15:07Carlos Henrique Del Carlo: HFpEF Reimagined as an Adipose Tissue Driven Disease
-
Apr 14, 2026, 15:05Matteo Foschi: ASPERA-R Study Reveals Competing Causes Of Breakthrough Stroke On Anticoagulation
-
Apr 14, 2026, 14:48Samwel Mikaye: From Virchow’s Triad to Prevention of PE in Patients with DVT